H aemoglobinopathies are recessively transmitted genetic diseases affecting haemoglobin; they are very common in areas of the world infected with malaria. Over the past few decades, these anomalies have spread throughout the world, as a result of shifts in various populations. During the past century, the Marseille region of France has witnessed different shifts in population and for that reason was thus the first region in France to have to deal with haemoglobinopathies, in the early 1950s. 1 2 The main origin for the patients was firstly Italy (before and after the second world war) and then North Africa (after the end of French colonisation). At present, patients come mainly from subsaharan Africa and from islands of the Indian Ocean. Also, a few of the carriers are people from the island of Corsica, the only place in France where β-thalassaemia is endemic, and people from the French overseas territories. A previous study found the frequency of heterozygotes for a major β globin gene defect to be 1% in the general Marseille population. 3 Preventive programmes involving detection of carriers have been instrumental in greatly reducing the number of new cases of children with these diseases in Mediterranean countries and also in countries where only a few people are involved. 4 5 Although they lead to two different diseases, both HbS carriers and β-thalassaemia trait carriers are usually screened together, as these diseases involve the same popula-tions. They are detected by the same blood test and lead to genetic counselling and prenatal diagnosis.
Here we report our experience with a systematic school screening for haemoglobinopathies that took place between 1978 and 1985 in high secondary schools of the Marseille region. To assess the impact of this preventive programme, we investigated several variables reflecting the influence of screening on the uptake of prenatal diagnosis.
METHODS

Systematic school screening
Screening took place from 1978 to 1985, and was aimed at all pupils aged 14-16.
A preliminary meeting designed to provide information was organised by either the school doctors, the science teachers, or the doctors and biologists from our team. During this educational session, the following points were covered: a clinical presentation of the disease, the genetic implication of recessive inheritance, the implication of the carrier status, and the opportunity for a carrier couple to seek prenatal diagnosis. The written consent of the parents, together with information on the geographical origins of families, was requested at this meeting. Then, 2 weeks later, samples were collected and analyzed: biological examinations included a haemogram and electrophoresis of haemoglobin on cellulose acetate. The HbA 2 fraction was assayed by chromatography when the mean cell volume was <80 fl. If the test showed a carrier status, results were reported to the participant during a consultation with a school doctor. The families were advised to arrange for a specialised consultation, so that a family study might be carried out. Genetic counselling was provided at the consultation by the doctor. The results were noted in the adolescents' medical records.
Testing of partners
To evaluate the partner's uptake for the testing, we sent a letter, together with an anonymous questionnaire composed of five questions (fig 1) to all the β-thalassaemia and HbS carriers detected during the school screening programme between 1978 and 1985.
Number of requests for genetic counselling since 1989
We compiled the charts of all couples from the Marseille area who underwent genetic counselling for haemoglobinopathies, and we investigated the reasons why each of these couples had resorted to counselling and how many prenatal diagnoses were performed.
Number of affected children born after one of the parents had been screened
We recorded the number of affected children born between 1980 and 1998, and noted the cases if one of the parents had previously been screened at school.
RESULTS
School screening programme
A total of 35 289 adolescents aged 14-16 were tested, 352 (1%) of whom were carriers (0.80% β-thalassaemia, 0.20% HbS).
This screening programme gave us access to two separate sets of data. Firstly, the epidemiological data were immediately analyzed and published at the end of the protocol. 3 The other data were the subject of a retrospective study, allowing us to evaluate the effectiveness of the programme 10-20 years later when the adolescents had become adults who wished to have a child.
Retrospective evaluation of the effectiveness of the screening in terms of partner testing
Half of the carriers replied to the questionnaire on the impact of the screening programme. The answers are summarised in figure 1 .
The replies showed several interesting facts.
• The written test result had not always been conserved (this was the lowest score) • Despite the latent period, the information had not been forgotten • The information had been well understood.
Retrospective evaluation of the effectiveness of the screening in terms of requests for genetic counselling
We estimated from the screening results that the cohort harboured three or four carrier couples. We identified a total of six couples: four of these couples were found to be at risk for β-thalassaemia and were identified because they requested genetic counselling; the other two couples were at risk for sickle cell disease and were identified because they gave birth to an affected child.
All four couples who asked for genetic counselling requested prenatal diagnosis. Eight prenatal diagnoses were performed. These were followed by three therapeutic terminations of pregnancy, as three foetuses were affected. These patients were either of Corsican, Italian, or Spanish origin.
Two couples in which one of the carrier members was detected by screening gave birth to two children homozygous for the βS allele. The first couple had declined genetic counselling, but in the case of the second couple, the information had been misunderstood by the student's parents and had not been conveyed. These patients were respectively of Caribbean and Algerian origin.
DISCUSSION
This school screening programme allowed five carrier couples to be fully informed about their carrier status before the first pregnancy and thus to choose between prenatal diagnosis (four couples) or an accepted risk of having an affected child (one couple).
At least one couple misunderstood the information and gave birth to an affected child because they were unaware of their status. We cannot exclude the existence of other carrier couples who would have normal or carrier children.
Despite the time lapse between screening, informing, and pregnancy (mean 14 years), the information was well conserved and resulted in testing of the partner (86% of the partners of carriers asked had had a haemoglobin test performed).
From the genetic counsellors, we know that school screening had a very positive impact on the decision making process. Knowing in advance that one is a carrier, and being aware of the possible consequences that might affect future children, makes it possible for a decision to be made calmly at the appropriate moment. Other studies of screening of pregnant women reported that, when the carrier couples are screened during the pregnancy, they have very little time to understand and come to terms with the causes and consequences, and their decision is sometimes difficult. 6 School screening was stopped for economic reasons and was replaced in 1986 by a targeted screening of women in healthcare centres, which is running today. 7 This screening is focused on communities at risk so it is more cost effective. It makes it possible to reach people over school age who are more concerned about having a child. The analysis of the populations reached by this programme shows that they differed widely from the school populations in geographical origin: the main origin of the people attending healthcare centres is Africa and North Africa, but the school population is mainly from the Mediterranean region. This is a reflection of change in the population as the population attending healthcare centres represents recent immigration whereas school populations at risk of haemoglobinopathies are the descendants of former migrants. Consequently, the type of haemoglobinopathies is different (sickle cell disease versus β-thalassaemia) as well as the behaviour regarding screening and prenatal diagnosis. 6 To reach different communities at risk, these two screening programmes should be organised concomitantly rather than alternatively.
The incidence graph of haemoglobin disorders in children born in the Marseille region since 1950 shows a decrease in the number of new cases of thalassaemia in the past 15 years (fig 2) . Prevention programmes have clearly contributed to this decrease. They have a lower impact on the birth rate of children with sickle cell disease because of a lower level of adhesion to prenatal diagnosis. 
